Thursday, 16 May 2019

Aurobindo Pharma Shares Tank 7% After USFDA Action

Aurobindo Pharma added it is confident that these OAI classifications will not have an impact on disruption of supplies or the revenue from operations of these facilities.

from Top Business News- News18.com http://bit.ly/2W0Rje3

post written by:

Related Posts

0 comments: